Enovis Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Public

  • Employees
  • 6,550

Employees

  • Stock Symbol
  • ENOV

Stock Symbol

  • Investments
  • 39

  • Share Price
  • $45.91
  • (As of Wednesday Closing)

Enovis General Information

Description

Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.

Contact Information

Website
www.enovis.com
Formerly Known As
Colfax Corporation
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Stock Exchange
NYS
Corporate Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States
+1 (302) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enovis Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$45.91 $46.02 $43.04 - $65.53 $2.52B 54.9M 631K -$1.50

Enovis Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 3,913,542 3,493,431 3,169,473 8,770,968
Revenue 1,817,312 1,707,197 1,563,101 1,426,188
EBITDA 143,670 169,721 224,883 94,331
Net Income (81,909) (33,261) (13,292) 71,657
Total Assets 5,478,681 4,509,334 4,273,248 8,515,912
Total Debt 1,412,930 536,416 334,819 2,164,811
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enovis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enovis‘s full profile, request access.

Request a free trial

Enovis Patents

Enovis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240130030-A1 Methods for mixing fluids for a plasma cutting torch Pending 17-Oct-2022 0000000000
US-20240123538-A1 Pistol grip for a processing torch Pending 12-Oct-2022 00000000
US-20240109145-A1 Wire feeder to torch communication Pending 30-Sep-2022 0000000000
US-20240066620-A1 Feeder mount for robotic welding system Pending 24-Aug-2022 000000000
US-20230311230-A1 Cancellation of the effects of primary voltage variations Pending 04-Apr-2022 B23K9/1062
To view Enovis’s complete patent history, request access »

Enovis Executive Team (35)

Name Title Board Seat
Matthew Trerotola Chief Executive Officer & Chairman
Gary Justak General Manager & President- Foot and Ankle
Louie Vogt President
Andrew Fox-Smith President of International Business (P&R and Mathys)
Christopher Hix Advisor
You’re viewing 5 of 35 executive team members. Get the full list »

Enovis Board Members (17)

Name Representing Role Since
0. 0000000 Enovis Board Member 000 0000
000000 00000 Enovis Board Member 000 0000
0000000 00000 Self Board Member 000 0000
00000 0000000 Enovis Chief Operating Officer, Operations & Board Member 000 0000
000000000 00000 Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

Enovis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enovis Investments & Acquisitions (39)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Limacorporate 03-Jan-2024 0000000000 00000 Therapeutic Devices 0000000 0
Precision AI Australia 05-Oct-2023 0000000000 000.00 Therapeutic Devices
SEAL External Fixation 20-Jul-2023 0000000000 000.00 Therapeutic Devices 0000 0000
Novastep 28-Jun-2023 0000000000 000.00 Other Devices and Supplies 0000000 0
Insight Medical Systems 05-Jul-2022 Merger/Acquisition Surgical Devices 0000000 0
You’re viewing 5 of 39 investments and acquisitions. Get the full list »

Enovis Subsidiaries (13)

Company Name Industry Location Founded
Precision AI Australia Therapeutic Devices Fortitude Valley, Australia 2019
Insight Medical Systems Surgical Devices Austin, TX 0000
360 Med Care Surgical Devices Pymble, Australia 0000
Novastep Other Devices and Supplies Englewood Cliffs, NJ 0000
Fairmount Automation Electrical Equipment West Conshohocken, PA 0000
You’re viewing 5 of 13 subsidiaries. Get the full list »

Enovis ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

31.77 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Healthcare

Industry

00 of 643

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 229

Rank

00.0

Percentile

To view Enovis’s complete esg history, request access »

Enovis Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Clarus Fluid Intelligence 09-Jul-2013 000000000000000000 000.00 Completed
  • 000000
To view Enovis’s complete exits history, request access »

Enovis FAQs

  • When was Enovis founded?

    Enovis was founded in 1995.

  • Who is the founder of Enovis?

    Steven Rales is the founder of Enovis.

  • Who is the CEO of Enovis?

    Matthew Trerotola is the CEO of Enovis.

  • Where is Enovis headquartered?

    Enovis is headquartered in Wilmington, DE.

  • What is the size of Enovis?

    Enovis has 6,550 total employees.

  • What industry is Enovis in?

    Enovis’s primary industry is Therapeutic Devices.

  • Is Enovis a private or public company?

    Enovis is a Public company.

  • What is Enovis’s stock symbol?

    The ticker symbol for Enovis is ENOV.

  • What is the current stock price of Enovis?

    As of 24-Jul-2024 the stock price of Enovis is $45.91.

  • What is the current market cap of Enovis?

    The current market capitalization of Enovis is $2.52B.

  • What is Enovis’s current revenue?

    The trailing twelve month revenue for Enovis is $1.82B.

  • What is Enovis’s annual earnings per share (EPS)?

    Enovis’s EPS for 12 months was -$1.50.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »